New syringe could make eye injections easier for macular degeneration patients
NCT ID NCT07214740
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a drug called pegcetacoplan, given as an eye injection using a prefilled syringe, in 44 people with geographic atrophy (a form of advanced age-related macular degeneration). The main goal was to see if the new syringe is safe and easy for doctors to use. The drug aims to slow the growth of blind spots in the center of vision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pegcetacoplan (a drug that targets part of the immune system to slow eye damage)
What this could lead to
If successful, this could provide a more convenient way to deliver pegcetacoplan, potentially slowing vision loss from geographic atrophy.
What could go wrong
This is a small, single-arm study focused on safety, not effectiveness. The drug may not work for everyone, and eye injections carry risks like infection or inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Retina Associates
Austin, Texas, 78705, United States
-
California Retina Consultants
Bakersfield, California, 93309, United States
-
California Retina Consultants
Oxnard, California, 93036, United States
-
Retina Consultants of Texas
Katy, Texas, 77494, United States
-
Retina Consultants of Texas
Woodland, Texas, 77384, United States